PCORI Answers Critical Questions
Evidence gaps can make it difficult to know which multiple sclerosis treatment will work best given a patient’s needs. PCORI funds studies that seek to help patients, clinicians and others answer various questions they might have about treatment options, such as:
Patient: I’m over 55 and my MS has been stable for years. Should I stay on my disease-modifying drug or consider a different treatment?
Clinician: In my rural community, would telerehabilitation be as effective as in-clinic rehabilitation? Would it provide a good option for patients without easy access to MS specialty centers?
Patient: Which of the available medications work best to treat my fatigue?
Multiple Sclerosis Study Spotlights
This study is using information from a Swedish database of patients with MS and from patients in Southern California with MS to look at how effective and safe rituximab is relative to other medicines used to treat MS over a period of up to nine years.
Hear about several comparative clinical effectiveness research studies that aim to help patients and those who care for them make better-informed decisions about their options for treating MS.
Clinics that provide exercise, yoga, and other nondrug therapies are scarce in rural and low-income areas. This study compares the benefits of an exercise program when patients receive it in a clinic versus at home via internet or telephone.